View More Recent Stories
-
Neurogene (NGNE) Receives RMAT Designation for NGN-401
-
BMO Capital Reiterates Outperform Rating on Neurogene (NGNE)
-
BMO Capital Starts Neurogene (NGNE) at Outperform
-
Baird Starts Neurogene (NGNE) at Outperform

